Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Receivables (2013 - 2026)

Xencor (XNCR) posted quarterly Receivables of $12.0 million for Q1 2026, down 68.24% year-over-year from $37.8 million in Q1 2025, and down 59.04% quarter-over-quarter from $29.3 million in Q4 2025.

Analysis

Xencor (XNCR) Receivables (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Receivables for 14 consecutive years, with $12.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Receivables fell 68.24% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (down 68.24% YoY), while the FY2025 annual figure was $29.3 million, down 55.97% from the prior year.
  • Receivables fell to $12.0 million in Q1 2026 per XNCR's latest filing, from $29.3 million in the prior quarter.
  • Across five years, Receivables topped out at $93.2 million in Q1 2022 and bottomed at $2.2 million in Q3 2023.
  • Historically, Receivables has averaged $34.7 million across 5 years, with a median of $29.3 million in 2025.
  • Annual changes were most pronounced in 2022 — Receivables soared 5328.4% — and 2023, when it tumbled 95.1%.
  • Xencor's Receivables stood at $30.3 million in 2022, then declined by 14.05% to $26.0 million in 2023, then surged by 155.57% to $66.5 million in 2024, then slumped by 55.97% to $29.3 million in 2025, then plunged by 59.04% to $12.0 million in 2026.
  • Business Quant data shows XNCR's Receivables at $12.0 million in Q1 2026, $29.3 million in Q4 2025, and $21.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 215.33 Mn
10 Xencor 2.02 Bn 1.65 Bn - 42.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.23 Mn
Mar 31, 2026 12.00 Mn
Dec 31, 2025 29.30 Mn
Sep 30, 2025 21.81 Mn
Jun 30, 2025 47.55 Mn
Mar 31, 2025 37.79 Mn
Dec 31, 2024 66.55 Mn
Sep 30, 2024 25.87 Mn
Jun 30, 2024 35.92 Mn
Mar 31, 2024 22.18 Mn
Dec 31, 2023 26.04 Mn
Sep 30, 2023 55.00 Mn
Jun 30, 2023 20.02 Mn
Mar 31, 2023 19.86 Mn
Dec 31, 2022 30.30 Mn
Sep 30, 2022 44.88 Mn
Jun 30, 2022 54.28 Mn
Mar 31, 2022 93.20 Mn
Dec 31, 2021 67.18 Mn
Sep 30, 2021 20.55 Mn